News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

January 2005

Correspondence regarding, "The Cost Effectiveness of Levalbuterol Versus Racemic Albuterol"

ByAlan L. Weiner, MD,Author reply by Campion Quinn, MD

January 15th 2005

Moving Towards Better Formulary Management

ByDana P. Goldman, PhD,Geoffrey F. Joyce, PhD

January 15th 2005

Clinical and Financial Outcomes Associated With a Proton Pump Inhibitor Prior-Authorization Program in a Medicaid Population

ByThomas Delate, PhD,Douglas E. Mager, BS,Jagat Sheth, PhD,Brenda R. Motheral, PhD

January 15th 2005

Variations of Physician Group Profiling Indicators for Asthma Care

ByI-Chan Huang, PhD,Gregory B. Diette, MD, MHS,Francesca Dominici, PhD,Constantine Frangakis, PhD,Albert W. Wu, MD, MPH

January 15th 2005

Do the Incentives in 3-Tier Pharmaceutical Benefit Plans Operate as Intended? Results From a Physician Leadership Survey

ByWilliam H. Shrank, MD, MSHS,Henry N. Young, PhD,Susan L. Ettner, PhD,Peter Glassman, MBBS, MSc,Steven M. Asch, MD, MPH,Richard L. Kravitz

January 15th 2005

Spillover Effects of Restrictive Drug Formularies: A Case Study of PacifiCare in California

ByY. Richard Wang, MD, PhD,Mark V. Pauly, PhD

January 15th 2005

Health Plan Members' Views on Forgiving Medical Errors

ByKathleen M. Mazor, EdD,Steven R. Simon, MD,Robert A. Yood, MD,Brian C. Martinson, PhD,Margaret J. Gunter, PhD,George W. Reed, PhD,Jerry H. Gurwitz, MD

January 15th 2005

Trending on AJMC

Senate Unveils Sweeping Bill to Reform 340B Drug Program

Gene Therapy for Wet AMD Near an Inflection Point: Arshad Khanani, MD

Brexpiprazole and Dextromethorphan-Bupropion: Mechanisms of Action and Key Clinical Trial Data for Approved Alzheimer's Disease Agitation Therapies

Trump Childhood Vaccine Order: What It Means for Parents and Payers

JAK Inhibitor Hesitancy and Step Therapy in Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD